XOMA Corporation (XOMAO)

24.99 -0.11 (-0.42%) 收市：04:00PM EDT

XOMA Corporation

2200 Powell Street
Suite 310
Emeryville, CA 94608
United States
510 204 7200
https://www.xoma.com

版塊: Healthcare
行業: Biotechnology
全職員工: 13

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Owen P. Hughes Jr.	CEO & Director	193.75k	無	1975
Mr. Thomas M. Burns	Senior VP of Finance & CFO	759.24k	無	1974
Mr. Brad Sitko	Chief Investment Officer	867.08k	無	1981

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

公司管治

截至 2024年5月1日 止，XOMA Corporation 的 ISS 管治質素評分為 3。 Pillar 分數正在審核中：5；董事會：3；股東權利：2；現金賠償：6。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。